Justin C Earp1, Debra C Dubois, Richard R Almon, William J Jusko. 1. Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, State University of New York at Buffalo, SUNY, 565 Hochstetter Hall, Buffalo, New York 14260, USA.
Abstract
PURPOSE: This comparison employs mathematical disease progression models to identify a rat model of arthritis with the least inter-animal variability and features lending to better study designs. METHODS: Arthritis was induced with either collagen (CIA) or mycobacterium (AIA) in either Lewis or Dark Agouti (DA) rats. Disease progression was monitored by paw edema and body weight. Models with production, loss, and feedback components were constructed and population analysis using NONMEM software was employed to identify inter-animal variability in the various disease progression parameters. RESULTS: Onset time was the only parameter different within all four groups (DA-AIA 11.5 days, DA-CIA 16.5 days, Lewis-AIA 11.9 days, Lewis-CIA 13.9 days). The loss-of-edema rate constant was 20% slower in DA (0.362 h(-1)) than Lewis (0.466 h(-1)) rats. Most models exhibited peak paw edema 20 days post-induction. Edema in CIA returned to 150% of the initial value after the disease peaked. DA rats displayed more severe overall responses. CONCLUSIONS: No statistical differences between groups were observed for inter-animal variation in disease onset, progression and severity parameters. Onset time varies and should be noted in the design of future studies. DA rats may offer a more dynamic range of edema response than Lewis rats.
PURPOSE: This comparison employs mathematical disease progression models to identify a rat model of arthritis with the least inter-animal variability and features lending to better study designs. METHODS:Arthritis was induced with either collagen (CIA) or mycobacterium (AIA) in either Lewis or Dark Agouti (DA) rats. Disease progression was monitored by paw edema and body weight. Models with production, loss, and feedback components were constructed and population analysis using NONMEM software was employed to identify inter-animal variability in the various disease progression parameters. RESULTS: Onset time was the only parameter different within all four groups (DA-AIA 11.5 days, DA-CIA 16.5 days, Lewis-AIA 11.9 days, Lewis-CIA 13.9 days). The loss-of-edema rate constant was 20% slower in DA (0.362 h(-1)) than Lewis (0.466 h(-1)) rats. Most models exhibited peak paw edema 20 days post-induction. Edema in CIA returned to 150% of the initial value after the disease peaked. DArats displayed more severe overall responses. CONCLUSIONS: No statistical differences between groups were observed for inter-animal variation in disease onset, progression and severity parameters. Onset time varies and should be noted in the design of future studies. DArats may offer a more dynamic range of edema response than Lewis rats.
Authors: Hoi-Kei Lon; Dongyang Liu; Qi Zhang; Debra C DuBois; Richard R Almon; William J Jusko Journal: Pharm Res Date: 2011-03-01 Impact factor: 4.200
Authors: Xiaonan Li; Debra C DuBois; Dawei Song; Richard R Almon; William J Jusko; Xijing Chen Journal: Drug Metab Dispos Date: 2017-04-17 Impact factor: 3.922